Analyst Price Targets — MASI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 17, 2026 2:44 pm | — | Stifel Nicolaus | $180.00 | $174.80 | TheFly | Masimo downgraded to Hold from Buy at Stifel |
| February 17, 2026 2:06 pm | Jason Bednar | Piper Sandler | $180.00 | $174.78 | TheFly | Masimo downgraded to Neutral from Overweight at Piper Sandler |
| December 5, 2025 11:11 am | — | Wells Fargo | $190.00 | $142.26 | TheFly | Masimo price target raised to $190 from $187 at Wells Fargo |
| December 4, 2025 12:23 pm | — | BTIG | $200.00 | $138.09 | TheFly | Masimo price target raised to $200 from $198 at BTIG |
| May 7, 2025 11:33 am | Marie Thibault | BTIG | $193.00 | $161.47 | TheFly | Masimo price target lowered to $193 from $206 at BTIG |
| December 18, 2024 1:46 pm | Jason Bednar | Piper Sandler | $210.00 | $170.63 | TheFly | Masimo price target raised to $210 from $180 at Piper Sandler |
| November 6, 2024 12:06 pm | Jayson Bedford | Raymond James | $170.00 | $150.71 | StreetInsider | Raymond James Upgrades Masimo Corp. (MASI) to Outperform |
| October 14, 2024 7:32 am | Marie Thibault | BTIG | $170.00 | $140.62 | TheFly | Masimo price target raised to $170 from $166 at BTIG |
| September 20, 2024 7:50 am | Jason Bednar | Piper Sandler | $165.00 | $114.61 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Masimo Corp. (MASI) |
| June 3, 2024 5:01 am | Jason Bednar | Piper Sandler | $160.00 | $124.50 | TheFly | Masimo upgraded to Overweight from Neutral at Piper Sandler |
Latest News for MASI
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous patient monitor.
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobius Merger Sub, Inc. (the “Merger…
MASI's SET pulse oximetry shows accurate, consistent readings in hospitalized newborns across all skin tones in the largest real-world study.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.